investigational

An investigational drug developed to treat a rare, inherited form of amyotrophic lateral sclerosis (ALS) reduced molecular signs of the fatal, paralyzing disease and curbed neurodegeneration -- but at six months, the drug did not improve…

Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of damaged nerves after spinal trauma. The research, published today in…

Researchers at Washington University School of Medicine in St. Louis have developed a way to attack synovial sarcoma -- a rare tumor of soft tissues, such as ligaments and muscles -- using an investigational drug that triggers cell death.…

A new paper in Annals of Neurology describes the approach, structure, and launch of the HEALEY ALS Platform Trial- the first platform trial for amyotrophic lateral sclerosis (ALS) designed to accelerate the development of effective and…

As SARS-CoV-2 continues to spread and mutate, it's important to identify new treatment options. Molnupiravir is an investigational oral antiviral being developed for the treatment of COVID-19, and has been submitted for review by the U.S.…